Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in Botswana
- PMID: 21698283
- PMCID: PMC3115945
- DOI: 10.1371/journal.pone.0020010
Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in Botswana
Abstract
Background: Adverse outcomes occurring early after antiretroviral therapy (ART) initiation are common in sub-Saharan Africa, despite reports of high levels of ART adherence in this setting. We sought to determine the relationship between very early ART adherence and early adverse outcomes in HIV-infected adults in Botswana.
Methods: This prospective cohort study of 402 ART-naïve, HIV-infected adults initiating ART at a public HIV clinic in Gaborone, Botswana evaluated the relationship between suboptimal early ART adherence and HIV treatment outcomes in the initial months after ART initiation. Early adherence during the interval between initial ART dispensation and first ART refill was calculated using pill counts. In the primary analysis patients not returning to refill and those with adherence <0.95 were considered to have suboptimal early adherence. The primary outcome was death or loss to follow-up during the first 6 months of ART; a secondary composite outcome included the primary outcome plus incident opportunistic illness (OIs) and virologic failure. We also calculated the percent of early adverse outcomes theoretically attributable to suboptimal early adherence using the population attributable risk percent (PAR%).
Results: Suboptimal early adherence was independently associated with loss to follow-up and death (adjusted OR 2.3, 95% CI 1.1-4.8) and with the secondary composite outcome including incident OIs and virologic failure (adjusted OR 2.6, 95% CI 1.4-4.7). However, of those with early adverse outcomes, less than one-third had suboptimal adherence and approximately two-thirds achieved virologic suppression. The PAR% relating suboptimal early adherence and primary and secondary outcomes were 14.7% and 17.7%, respectively.
Conclusions: Suboptimal early adherence was associated with poor outcomes, but most early adverse outcomes occurred in patients with optimal early adherence. Clinical care and research efforts should focus on understanding early adverse outcomes that occur despite optimal adherence.
Conflict of interest statement
Similar articles
-
Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts.J Int AIDS Soc. 2017 Mar 3;20(1):21218. doi: 10.7448/IAS.20.1.21218. J Int AIDS Soc. 2017. PMID: 28362063 Free PMC article.
-
Risk factors for suboptimal antiretroviral therapy adherence in HIV-infected adolescents in Gaborone, Botswana: a pilot cross-sectional study.Patient Prefer Adherence. 2013 Sep 11;7:891-5. doi: 10.2147/PPA.S47628. eCollection 2013. Patient Prefer Adherence. 2013. PMID: 24049440 Free PMC article.
-
Effect of peer health workers on AIDS care in Rakai, Uganda: a cluster-randomized trial.PLoS One. 2010 Jun 2;5(6):e10923. doi: 10.1371/journal.pone.0010923. PLoS One. 2010. PMID: 20532194 Free PMC article. Clinical Trial.
-
Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008494. doi: 10.1002/14651858.CD008494. Cochrane Database Syst Rev. 2010. PMID: 20393969 Review.
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
Cited by
-
Case report: Multicentric Castleman disease as a manifestation of immune reconstitution inflammatory syndrome in Malawi.Front Oncol. 2022 Dec 12;12:969135. doi: 10.3389/fonc.2022.969135. eCollection 2022. Front Oncol. 2022. PMID: 36578926 Free PMC article.
-
Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults.AIDS. 2017 Oct 23;31(16):2217-2225. doi: 10.1097/QAD.0000000000001606. AIDS. 2017. PMID: 28742529 Free PMC article.
-
Marked sex differences in all-cause mortality on antiretroviral therapy in low- and middle-income countries: a systematic review and meta-analysis.J Int AIDS Soc. 2016 Nov 8;19(1):21106. doi: 10.7448/IAS.19.1.21106. eCollection 2016. J Int AIDS Soc. 2016. PMID: 27834182 Free PMC article. Review.
-
Effects of sex and alcohol use on antiretroviral therapy outcomes in Botswana: a cohort study.Addiction. 2017 Jan;112(1):73-81. doi: 10.1111/add.13538. Epub 2016 Sep 7. Addiction. 2017. PMID: 27447841 Free PMC article.
-
Measuring Health Literacy Among Adults with HIV Infection in Mozambique: Development and Validation of the HIV Literacy Test.AIDS Behav. 2017 Mar;21(3):822-832. doi: 10.1007/s10461-016-1348-3. AIDS Behav. 2017. PMID: 26961538 Free PMC article.
References
-
- Marazzi MC, Liotta G, Germano P, Guidotti G, Altan AD, et al. Excessive early mortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings. AIDS Res Hum Retroviruses. 2008;24:555–560. - PubMed
-
- Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006;296:679–690. - PubMed
-
- Park WB, Choe PG, Kim SH, Jo JH, Bang JH, et al. One-year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patients. J Intern Med. 2007;261:268–75. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical